IS5534A - Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum - Google Patents

Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum

Info

Publication number
IS5534A
IS5534A IS5534A IS5534A IS5534A IS 5534 A IS5534 A IS 5534A IS 5534 A IS5534 A IS 5534A IS 5534 A IS5534 A IS 5534A IS 5534 A IS5534 A IS 5534A
Authority
IS
Iceland
Prior art keywords
headache
local anesthetic
new use
anesthetic agents
agents
Prior art date
Application number
IS5534A
Other languages
English (en)
Icelandic (is)
Inventor
Dalsgaard Carl-Johan
Eek Arne
Waldenlind Lennart
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS5534A publication Critical patent/IS5534A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
IS5534A 1997-12-19 2000-06-15 Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum IS5534A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704770A SE9704770D0 (sv) 1997-12-19 1997-12-19 New use
PCT/SE1998/002299 WO1999032103A1 (en) 1997-12-19 1998-12-14 New use of local anaesthetics against vascular headaches

Publications (1)

Publication Number Publication Date
IS5534A true IS5534A (is) 2000-06-15

Family

ID=20409476

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5534A IS5534A (is) 1997-12-19 2000-06-15 Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum

Country Status (18)

Country Link
EP (1) EP1047412A1 (id)
JP (1) JP2001526217A (id)
KR (1) KR20010024768A (id)
CN (1) CN1282241A (id)
AU (1) AU1898199A (id)
BR (1) BR9813775A (id)
CA (1) CA2314452A1 (id)
EE (1) EE200000394A (id)
HU (1) HUP0100599A3 (id)
ID (1) ID26703A (id)
IL (1) IL136518A0 (id)
IS (1) IS5534A (id)
NO (1) NO20003138L (id)
PL (1) PL341283A1 (id)
SE (1) SE9704770D0 (id)
SK (1) SK7832000A3 (id)
TR (1) TR200001926T2 (id)
WO (1) WO1999032103A1 (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
WO2000044432A1 (en) 1999-01-27 2000-08-03 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
AU2100901A (en) * 1999-12-15 2001-06-25 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
UA123759C2 (uk) 2014-03-21 2021-06-02 Тева Фармасьютікалз Інтернешнл Гмбх Застосування моноклонального антитіла, яке інгібує шлях пов'язаного з геном кальциноніну пептиду (cgrp), для лікування або зниження частоти випадків мігренозного головного болю у суб'єкта
ES2846878T3 (es) * 2015-09-24 2021-07-30 Teva Pharmaceuticals Int Gmbh Prevenir, tratar y reducir el dolor de cabeza post-traumático (persistente)
US10392434B2 (en) 2016-09-23 2019-08-27 Teva Pharmaceuticals International Gmbh Treating refractory migraine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) * 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
US3988475A (en) * 1974-02-05 1976-10-26 Istituto Luso Farmaco D'italia S.R.L. Phenoxyalkylamines
AR004691A1 (es) * 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Also Published As

Publication number Publication date
ID26703A (id) 2001-02-01
BR9813775A (pt) 2000-10-10
KR20010024768A (ko) 2001-03-26
WO1999032103A1 (en) 1999-07-01
NO20003138L (no) 2000-08-18
JP2001526217A (ja) 2001-12-18
NO20003138D0 (no) 2000-06-16
IL136518A0 (en) 2001-06-14
CN1282241A (zh) 2001-01-31
SK7832000A3 (en) 2001-02-12
EE200000394A (et) 2001-12-17
PL341283A1 (en) 2001-04-09
TR200001926T2 (tr) 2000-11-21
AU1898199A (en) 1999-07-12
HUP0100599A2 (hu) 2002-02-28
EP1047412A1 (en) 2000-11-02
HUP0100599A3 (en) 2002-04-29
SE9704770D0 (sv) 1997-12-19
CA2314452A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
FI970310A (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
NO993068L (no) Ny forbindelsesform
NO992806L (no) Terapeutiske midler
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
ID18679A (id) Penggunaan terapi lanjutan
NO20001847D0 (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
NO993298D0 (no) Ny fremgangsmÕte
EE04439B1 (et) 5HT1 antagonistid antidepressantraviks
ID21424A (id) Konfigurasi katup gabungan untuk unit siklus-uap
NO995147D0 (no) Kontrastmidler
NO995796D0 (no) Ny fremgangsmåte
IS5534A (is) Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum
EE9600160A (et) Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel
NO993438D0 (no) Kontrastmidler for ultralyd
EE9600127A (et) Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel
IS5814A (is) Ný lyfjafræðileg notkun á NOS lötum
IS4320A (is) Ný súbstitúeruð bensimidasól
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
FI974235A0 (fi) Ny bestaemningsmetod
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
SE9702595D0 (sv) new therapeutic use
FI970807A (fi) Tiosemikarbatsidien käyttö lahonestoaineina
BR1101089A (pt) Composição terapêutica de uso nasal
SE9802023D0 (sv) New therapeutic use